Pfizer Ceo
-
{
- All
- News
- Videos
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
